Income Statement JD Health International Inc.

Stocks

6618

KYG5074A1004

Drug Retailers

Market Closed - Hong Kong S.E. Other stock markets 04:08:30 2026-06-11 am EDT			5-day change	1st Jan Change
37.90 ^HKD	-0.21%		-0.52%	-31.71%

May. 15	Nomura Adjusts JD Health International's Price Target to HK$67 from HK$80, Keeps at Buy	MT
May. 12	JD Health International's Profit Jumps 78% in Q1; Share Buyback Proposed	MT

a87061.hckLf8QwwXHQtm-cPFHMkXlgLve0IqBW4l_idVyg4NM.9qNeFaJJqQC--lfzDWeh4BAjGc7uQNY_ijalLTvNl6HNqD0lnVaAMI_lOg

Published financial data: JD HEALTH INTERNATIONAL INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	30.68B	46.74B	53.53B	58.16B	73.44B
Total Revenues	30.68B	46.74B	53.53B	58.16B	73.44B
Cost of Goods Sold, Total	23.48B	36.84B	41.66B	44.85B	55.24B
Gross Profit	7.2B	9.89B	11.87B	13.31B	18.2B
Selling General & Admin Expenses, Total	7.67B	8.87B	9.94B	10.5B	12.62B
Provision for Bad Debts	38.35M	98.2M	69.86M	316M	143M
R&D Expenses	893M	1.07B	1.23B	1.33B	1.63B
Other Operating Expenses, Total	8.6B	10.04B	11.23B	12.15B	14.4B
Operating Income	-1.4B	-145M	631M	1.16B	3.8B
Interest Expense, Total	-6M	-9.1M	-9.48M	-8.19M	-11.1M
Interest And Investment Income	458M	864M	1.95B	1.96B	1.54B
Net Interest Expenses	452M	855M	1.94B	1.95B	1.53B
Income (Loss) On Equity Invest.	-94.16M	-96.76M	-70.76M	-85.53M	-64.05M
Other Non Operating Income (Expenses)	145M	82.52M	194M	1.77B	770M
EBT, Excl. Unusual Items	-901M	696M	2.69B	4.8B	6.03B
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-901M	696M	2.69B	4.8B	6.03B
Income Tax Expense	171M	313M	550M	640M	663M
Earnings From Continuing Operations	-1.07B	383M	2.14B	4.16B	5.37B
Net Income to Company	-1.07B	383M	2.14B	4.16B	5.37B
Minority Interest	-689K	-3.12M	-1.04M	4.83M	8.3M
Net Income - (IS)	-1.07B	380M	2.14B	4.16B	5.38B
Net Income to Common Incl Extra Items	-1.07B	380M	2.14B	4.16B	5.38B
Net Income to Common Excl. Extra Items	-1.07B	380M	2.14B	4.16B	5.38B
Per Share Items
Net EPS - Basic	-0.35	0.12	0.69	1.32	1.7
Basic EPS - Continuing Operations	-0.35	0.12	0.69	1.32	1.7
Basic Weighted Average Shares Outstanding	3.09B	3.11B	3.12B	3.14B	3.16B
Net EPS - Diluted	-0.35	0.12	0.68	1.32	1.68
Diluted EPS - Continuing Operations	-0.35	0.12	0.68	1.32	1.68
Diluted Weighted Average Shares Outstanding	3.09B	3.14B	3.16B	3.16B	3.2B
Normalized Basic EPS	-0.18	0.14	0.54	0.96	1.19
Normalized Diluted EPS	-0.18	0.14	0.53	0.95	1.18
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-1.37B	-60.93M	795M	1.31B	3.98B
EBITA	-1.4B	-145M	756M	1.28B	3.92B
EBIT	-1.4B	-145M	631M	1.16B	3.8B
Effective Tax Rate - (Ratio)	-19	44.92	20.44	13.34	10.99
Current Domestic Taxes	227M	414M	454M	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	227M	414M	454M	504M	741M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-55.64M	-102M	96.2M	135M	-78.04M
Normalized Net Income	-564M	432M	1.68B	3B	3.78B
Interest on Long-Term Debt	6M	9.1M	9.48M	8.19M	11.1M
Supplemental Operating Expense Items
Advertising Expense	-	922M	1.3B	1.56B	1.93B
Selling and Marketing Expenses	2.13B	2.2B	2.65B	3.05B	3.84B
General and Administrative Expenses	2.54B	2.15B	2B	1.42B	1.16B
Research And Development Expense From Footnotes	893M	1.07B	1.23B	1.33B	1.63B
Stock-Based Comp., R&D Exp. (Total)	98.86M	106M	106M	80.18M	26.94M
Stock-Based Comp., S&M Exp. (Total)	37.94M	49.38M	40.29M	25.61M	6.16M
Stock-Based Comp., G&A Exp. (Total)	2.31B	1.81B	1.57B	930M	543M
Stock-Based Comp., SG&A Exp. (Total)	134M	142M	126M	94.15M	15.07M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	2.58B	2.1B	1.85B	1.13B	591M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	17.25B	18.72B	15.04B	22.63B	31.78B
Short Term Investments	23.64B	27.95B	16.8B	18.17B	15.86B
Trading Asset Securities, Total	1.1B	1B	9.38B	10.44B	501M
Total Cash And Short Term Investments	41.99B	47.67B	41.22B	51.24B	48.15B
Accounts Receivable, Total	406M	1.3B	707M	858M	743M
Other Receivables	51.16M	687M	265M	289M	366M
Total Receivables	457M	1.99B	972M	1.15B	1.11B
Inventory	3.04B	6B	5.08B	5.84B	6.86B
Prepaid Expenses	14.03M	15.79M	16.35M	20.72M	33.2M
Restricted Cash	25.35M	33M	15.38M	32.66M	7.74M
Other Current Assets, Total	178M	742M	540M	182M	191M
Total Current Assets	45.71B	56.45B	47.85B	58.46B	56.35B
Net Property Plant And Equipment	261M	252M	288M	796M	1.23B
Long-term Investments	1.03B	1.52B	13.2B	9.58B	21.64B
Other Intangibles, Total	25.39M	2.27B	2.18B	2.09B	1.93B
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	95.86M	208M	300M	313M	399M
Other Long-Term Assets, Total	884M	579M	472M	26.88M	31.43M
Total Assets	48B	61.28B	64.29B	71.27B	81.59B
Liabilities
Accounts Payable, Total	5.71B	11.14B	11.34B	12.48B	16.59B
Accrued Expenses, Total	178M	1.2B	306M	392M	694M
Current Portion of Leases	67.55M	70.65M	95.32M	110M	207M
Current Income Taxes Payable	119M	380M	338M	207M	598M
Unearned Revenue Current, Total	395M	1.37B	406M	538M	552M
Other Current Liabilities	1.53B	2.18B	2.1B	1.79B	2.1B
Total Current Liabilities	8.01B	16.36B	14.58B	15.52B	20.74B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	134M	129M	119M	149M	429M
Deferred Tax Liability Non Current	8.89M	7.82M	214M	364M	343M
Total Liabilities	8.15B	16.49B	14.92B	16.03B	21.51B
Common Stock, Total	11K	11K	11K	11K	11K
Additional Paid In Capital	56.24B	57.06B	58.55B	59.98B	61.42B
Retained Earnings	-19.68B	-19.38B	-17.34B	-13.22B	-7.97B
Treasury Stock	-50.64M	-34.3M	-92.57M	-60.73M	-34.54M
Comprehensive Income and Other	3.34B	7.13B	8.23B	8.54B	6.65B
Total Common Equity	39.85B	44.78B	49.36B	55.23B	60.07B
Minority Interest	1.19M	4.31M	14.51M	9.68M	1.39M
Total Equity	39.85B	44.78B	49.37B	55.24B	60.07B
Total Liabilities And Equity	48B	61.28B	64.29B	71.27B	81.59B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.1B	3.11B	3.13B	3.15B	3.17B
ECS Total Common Shares Outstanding	3.1B	3.11B	3.13B	3.15B	3.17B
Book Value / Share	12.86	14.42	15.78	17.56	18.97
Tangible Book Value	39.83B	42.51B	47.17B	53.14B	58.14B
Tangible Book Value Per Share	12.86	13.69	15.08	16.89	18.36
Total Debt	201M	199M	215M	258M	636M
Net Debt	-41.79B	-47.47B	-41.01B	-50.98B	-47.51B
Minority Interest, Total (Incl. Fin. Div)	1.19M	4.31M	14.51M	9.68M	1.39M
Equity Method Investments, Total	512M	418M	348M	264M	200M
Account Code - Inventory Valuation	6	6	-	6	6
Inventories - Finished Goods, Total	3.11B	6.26B	5.47B	5.99B	7.01B
Full Time Employees	3.3K	2.74K	3.12K	3.56K	5.26K
Accumulated Allowance for Doubtful Accounts (Supple)	44.72M	143M	213M	220M	360M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-1.07B	380M	2.14B	4.16B	5.38B
Depreciation & Amortization - CF	63.17M	141M	103M	95.86M	161M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	125M	119M	119M
Depreciation & Amortization, Total	63.17M	141M	227M	215M	280M
(Gain) Loss on Sale of Investments - (CF)	-94.21M	106M	-93.51M	-1.35B	-354M
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	94.16M	96.76M	70.76M	85.53M	64.05M
Stock-Based Compensation (CF)	2.58B	2.1B	1.85B	1.13B	591M
Provision and Write-off of Bad Debts	38.35M	98.2M	69.86M	316M	143M
Other Operating Activities, Total	-204M	130M	126M	-755M	473M
Change In Accounts Receivable	-331M	-685M	537M	-213M	-27.72M
Change In Inventories	-1.29B	-3.15B	792M	-523M	-1.02B
Change In Accounts Payable	2.59B	5.04B	-866M	760M	2.79B
Change in Unearned Revenues	216M	980M	-969M	132M	14.39M
Change in Other Net Operating Assets	843M	665M	721M	369M	1.85B
Cash from Operations	3.43B	5.91B	4.6B	4.33B	10.17B
Capital Expenditure	-502M	-40.16M	-61.18M	-38.6M	-151M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-7.88M	-2.23B	-	-	-
Investment in Marketable and Equity Securities, Total	-17.25B	-1.96B	-7.97B	3.21B	-465M
Other Investing Activities, Total	5.18M	-5.41M	9.48M	-25.04M	24.92M
Cash from Investing	-17.75B	-4.24B	-8.02B	3.15B	-591M
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-32.33M	-47.56M	-33.83M	-37.41M	-68.05M
Total Debt Repaid	-32.33M	-47.56M	-33.83M	-37.41M	-68.05M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-56.3M	-869M	-69.1M	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-75.02M	-8.85M	-14.26M	-8.19M	-11.1M
Cash from Financing	-164M	-925M	-117M	-45.61M	-79.15M
Foreign Exchange Rate Adjustments	-533M	721M	-145M	159M	-348M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-15.02B	1.47B	-3.68B	7.59B	9.16B
Supplemental Items
Cash Interest Paid	4.91M	8.85M	9.48M	8.19M	11.1M
Cash Income Tax Paid (Refund)	250M	153M	497M	635M	350M
Levered Free Cash Flow	3.22B	3.16B	2.75B	2.35B	7.24B
Unlevered Free Cash Flow	3.23B	3.17B	2.76B	2.36B	7.24B
Change In Net Working Capital	-1.97B	-3.29B	-351M	-326M	-4.15B
Net Debt Issued / Repaid	-32.33M	-47.56M	-33.83M	-37.41M	-68.05M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-1.91	-0.17	0.63	1.07	3.11
Return on Total Capital	-2.21	-0.21	0.83	1.38	4.09
Return On Equity %	-2.71	0.91	4.55	7.95	9.31
Return on Common Equity	-2.71	0.9	4.55	7.96	9.32
Margin Analysis
Gross Profit Margin %	23.46	21.16	22.17	22.88	24.78
SG&A Margin	25	18.98	18.57	18.05	17.19
EBITDA Margin %	-4.47	-0.13	1.48	2.26	5.41
EBITA Margin %	-4.58	-0.31	1.41	2.2	5.33
EBIT Margin %	-4.58	-0.31	1.18	2	5.17
Income From Continuing Operations Margin %	-3.5	0.82	4	7.15	7.31
Net Income Margin %	-3.5	0.81	4	7.16	7.32
Net Avail. For Common Margin %	-3.5	0.81	4	7.16	7.32
Normalized Net Income Margin	-1.84	0.92	3.14	5.16	5.14
Levered Free Cash Flow Margin	10.5	6.77	5.14	4.05	9.85
Unlevered Free Cash Flow Margin	10.51	6.78	5.15	4.05	9.86
Asset Turnover
Asset Turnover	0.67	0.86	0.85	0.86	0.96
Fixed Assets Turnover	163.3	182.32	198.29	107.31	72.49
Receivables Turnover (Average Receivables)	70.82	54.76	53.32	74.34	91.76
Inventory Turnover (Average Inventory)	9.84	8.15	7.52	8.21	8.7
Short Term Liquidity
Current Ratio	5.71	3.45	3.28	3.77	2.72
Quick Ratio	5.3	3.04	2.89	3.37	2.37
Operating Cash Flow to Current Liabilities	0.43	0.36	0.32	0.28	0.49
Days Sales Outstanding (Average Receivables)	5.15	6.66	6.85	4.92	3.98
Days Outstanding Inventory (Average Inventory)	37.1	44.76	48.54	44.58	41.96
Average Days Payable Outstanding	63.38	77.28	100.68	95.59	94.3
Cash Conversion Cycle (Average Days)	-21.13	-25.85	-45.3	-46.08	-48.37
Long Term Solvency
Total Debt/Equity	0.5	0.45	0.43	0.47	1.06
Total Debt / Total Capital	0.5	0.44	0.43	0.47	1.05
LT Debt/Equity	0.34	0.29	0.24	0.27	0.71
Long-Term Debt / Total Capital	0.33	0.29	0.24	0.27	0.71
Total Liabilities / Total Assets	16.97	26.91	23.2	22.5	26.37
EBIT / Interest Expense	-234.05	-15.95	66.51	141.92	342.22
EBITDA / Interest Expense	-223.52	-0.49	90.49	168.12	367.45
(EBITDA - Capex) / Interest Expense	-307.23	-4.9	84.04	163.41	353.85
Total Debt / EBITDA	-0.15	-44.87	0.25	0.19	0.16
Net Debt / EBITDA	31.17	10.68K	-47.78	-37	-11.65
Total Debt / (EBITDA - Capex)	-0.11	-4.47	0.27	0.19	0.16
Net Debt / (EBITDA - Capex)	22.67	1.06K	-51.44	-38.07	-12.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	58.3	52.32	14.54	8.65	26.28
Gross Profit, 1 Yr. Growth %	46.37	37.43	19.95	12.16	36.75
EBITDA, 1 Yr. Growth %	-476.3	-95.56	-1.4K	65.41	202.34
EBITA, 1 Yr. Growth %	-499.33	-89.66	-892.88	69.63	205.6
EBIT, 1 Yr. Growth %	-499.33	-89.66	-534.71	84.34	226.59
Earnings From Cont. Operations, 1 Yr. Growth %	-93.78	-135.72	459.16	93.99	29.11
Net Income, 1 Yr. Growth %	-93.77	-135.41	463.49	94.31	29.16
Normalized Net Income, 1 Yr. Growth %	-94.71	-176.54	289.64	78.49	25.79
Diluted EPS Before Extra, 1 Yr. Growth %	-95.56	-134.29	466.67	94.12	27.27
Accounts Receivable, 1 Yr. Growth %	-11.97	220.72	-45.68	21.39	-13.41
Inventory, 1 Yr. Growth %	75.55	97.16	-15.2	14.91	17.38
Net Property, Plant and Equip., 1 Yr. Growth %	126.75	-3.4	14.32	176.39	54.55
Total Assets, 1 Yr. Growth %	9.11	27.66	4.91	10.87	14.47
Tangible Book Value, 1 Yr. Growth %	1.54	6.74	10.96	12.64	9.41
Common Equity, 1 Yr. Growth %	1.54	12.36	10.22	11.9	8.76
Cash From Operations, 1 Yr. Growth %	-7.26	72.13	-22.02	-5.92	134.84
Capital Expenditures, 1 Yr. Growth %	3.1K	-92	52.35	-36.91	225.77
Levered Free Cash Flow, 1 Yr. Growth %	-9.58	-1.8	-12.98	-14.54	208.56
Unlevered Free Cash Flow, 1 Yr. Growth %	-9.52	-1.73	-12.95	-14.53	208.18
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	68.22	55.28	32.09	11.55	17.13
Gross Profit, 2 Yr. CAGR %	59.98	41.83	28.4	15.99	23.85
EBITDA, 2 Yr. CAGR %	77.19	-59.11	-23.87	364.54	123.63
EBITA, 2 Yr. CAGR %	80.37	-35.75	-26.64	266.74	127.68
EBIT, 2 Yr. CAGR %	80.37	-35.75	-32.97	183.08	145.37
Earnings From Cont. Operations, 2 Yr. CAGR %	5.07	-85.09	41.33	229.35	58.26
Net Income, 2 Yr. CAGR %	5.1	-85.15	41.25	230.9	58.42
Normalized Net Income, 2 Yr. CAGR %	45.15	-79.88	72.69	163.72	49.84
Diluted EPS Before Extra, 2 Yr. CAGR %	-12.41	-87.6	39.39	231.66	57.18
Accounts Receivable, 2 Yr. CAGR %	-34.69	68.02	31.99	-18.8	2.52
Inventory, 2 Yr. CAGR %	54.24	86.04	29.3	-1.29	16.14
Net Property, Plant and Equip., 2 Yr. CAGR %	301.28	48	5.09	77.76	106.68
Total Assets, 2 Yr. CAGR %	135.21	18.02	15.73	7.85	12.65
Tangible Book Value, 2 Yr. CAGR %	830.87	4.11	8.83	11.8	11.02
Common Equity, 2 Yr. CAGR %	831.78	6.81	11.28	11.06	10.32
Cash From Operations, 2 Yr. CAGR %	189.46	26.34	15.85	-14.35	48.64
Capital Expenditures, 2 Yr. CAGR %	884.07	59.94	-65.1	-1.96	57.1
Levered Free Cash Flow, 2 Yr. CAGR %	228.35	-5.77	-7.56	-13.76	62.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	216.98	-5.71	-7.51	-13.75	62.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	55.44	62.75	40.3	23.76	16.26
Gross Profit, 3 Yr. CAGR %	53.78	52.08	34.13	22.74	22.54
EBITDA, 3 Yr. CAGR %	64.63	-48.14	29.68	-1.4	302.57
EBITA, 3 Yr. CAGR %	66.77	-30.46	29.05	-2.99	245.11
EBIT, 3 Yr. CAGR %	66.77	-30.46	21.51	-6.09	196.9
Earnings From Cont. Operations, 3 Yr. CAGR %	70.9	-26.67	-50.09	57.07	141.04
Net Income, 3 Yr. CAGR %	70.94	-26.87	-50.1	57.09	141.83
Normalized Net Income, 3 Yr. CAGR %	43.38	17.26	-45.98	74.6	106.05
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-35.74	-55.67	55.66	141.01
Accounts Receivable, 3 Yr. CAGR %	171.2	11.01	15.32	28.36	-17.04
Inventory, 3 Yr. CAGR %	39.71	67.4	43.18	24.31	4.58
Net Property, Plant and Equip., 3 Yr. CAGR %	290.81	149.63	35.8	45.06	69.66
Total Assets, 3 Yr. CAGR %	243.71	91.86	13.48	14.08	10.01
Tangible Book Value, 3 Yr. CAGR %	276.47	352.24	6.35	10.09	11
Common Equity, 3 Yr. CAGR %	276.08	360.34	7.94	11.49	10.29
Cash From Operations, 3 Yr. CAGR %	163.64	143.41	7.57	8.09	19.88
Capital Expenditures, 3 Yr. CAGR %	529.53	97.84	57.37	-57.48	55.5
Levered Free Cash Flow, 3 Yr. CAGR %	175.32	119.58	-8.24	-9.94	31.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	175.37	114.53	-8.19	-9.91	31.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	53.12	45.64	39.93	30.53
Gross Profit, 5 Yr. CAGR %	-	48.27	43.08	36.46	29.92
EBITDA, 5 Yr. CAGR %	-	-25.1	20.93	24.65	61.26
EBITA, 5 Yr. CAGR %	-	-10.75	20.07	24.32	61.95
EBIT, 5 Yr. CAGR %	-	-10.75	15.82	21.93	60.95
Earnings From Cont. Operations, 5 Yr. CAGR %	-	16.51	58.4	33.73	-20.81
Net Income, 5 Yr. CAGR %	-	16.32	58.38	33.76	-20.79
Normalized Net Income, 5 Yr. CAGR %	-	21.96	54.45	62.16	-18.75
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	23.9	-26.45
Accounts Receivable, 5 Yr. CAGR %	-	234.11	103.32	-2.04	10.02
Inventory, 5 Yr. CAGR %	-	46.65	35.45	35.52	31.68
Net Property, Plant and Equip., 5 Yr. CAGR %	-	131.83	131.1	117.92	60.64
Total Assets, 5 Yr. CAGR %	-	132.02	122.38	52.38	13.15
Tangible Book Value, 5 Yr. CAGR %	-	130.25	129.16	158.58	8.19
Common Equity, 5 Yr. CAGR %	-	132.25	131.07	160.66	8.88
Cash From Operations, 5 Yr. CAGR %	-	177.14	89.74	60.29	22.42
Capital Expenditures, 5 Yr. CAGR %	-	116.62	97.95	49.4	57.26
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	77.93	51.09	15.22
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	77.99	49.01	15.23